Teclistamab

1 Drug classified under this active ingredient

anti-CD3, Antineoplastic, Monoclonal Antibody. Teclistamab 10 mg/ml, 90 mg/ml.
VIAL Sol. for inj.3 ml
Recomm. doses are 1.5 mg/kg by SC inj. weekly, preceded by step-up doses of 0.06 mg/kg and 0.3 mg/kg.  See full prescr. info.
 As monother. for adults with relapsed and refractory multiple myeloma, who have received at least 3 prior ther., incl. an immunomodulatory agent, a proteasome inhibit., and an anti-CD38 antibody and have demonstrated dis. progress. on the last ther.
C/I:Hypersens.